70.6 F
Fort Worth
Wednesday, September 23, 2020
- Advertisements -
Health Care Theranos corrects tens of thousands of blood-testing results

Theranos corrects tens of thousands of blood-testing results

Other News

Wall Street posts solid gains after surge in corporate deals

By ALEX VEIGA and DAMIAN J. TROISE AP Business Writers Wall Street kicked off the week with a broad...

Tarrant County ranks low in work-from-home study by NAR

North Texas ranks pretty high in the “Work from Home” category, according to a just-released study by the National Association of Realtors....

Commentary: Universities and COVID-19: Charting turbulent times

Ray Perryman As the COVID-19 pandemic emerged this spring, college campuses across the United States swiftly sent students...

Linear Labs introduces electric motor that will fit inside a pocket

Leading the new wave of electrification, a Fort Worth-based technology company has built an electric motor that can fit inside one's pocket,...

Blood-testing startup Theranos said it sent doctors and patients tens of thousands of corrected test results and voided two years of data from its devices, a devastating blow for the company that has come under scrutiny over the accuracy of its technology.

The Silicon Valley startup told federal health regulators at the Centers for Medicare and Medicaid Services that it had voided results from 2014 and 2015 generated by its testing devices, the Wall Street Journal reported. Theranos spokeswoman Brooke Buchanan confirmed the report by email.

“Excellence in quality and patient safety is our top priority and we’ve taken comprehensive corrective measures to address the issues CMS raised in their observations,” Buchanan said in an email. “As these matters are currently under review, we have no further comment at this time.”

Lauren Shaham, a spokeswoman for CMS, declined to comment.

Theranos is developing a technology that, the company has said, can run scores of diagnostic tests using only a few drops of blood. The Palo Alto, California-based startup has faced questions about whether its technology works and has been subject to investigations by the U.S. Securities and Exchange Commission, the U.S. Attorney’s Office in San Francisco, and federal and state health regulators.

President and Chief Operating Officer Sunny Balwani left the company last week, saying he was retiring. At the same time, Theranos reconfigured its board, adding former Amgen Inc. executive Fabrizio Bonanni.

Theranos’s business has grown mainly through its partnership with Walgreens Boots Alliance, with about 40 of its testing centers placed in Walgreens outlets in Arizona. Walgreens spokesman Michael Polzin declined to comment on whether the drugstore chain would continue working with Theranos.

- Advertisements -
- Advertisements -

Latest News

Tarrant County reports five COVID deaths on Wednesday

Tarrant County Public Health reported five COVID-19 deaths on Wednesday, Sept. 23. The deceased include a woman from Bedford in her 90s,...

Tarrant County reports 3 COVID deaths on Tuesday

Tarrant County Public Health reported three COVID-19 deaths on Tuesday, Sept. 22. The deceased include a woman from Fort Worth in her...

Fort Worth police partner with MHMR and The Morris Foundation on mental health

The Fort Worth Police Department, with funding from The Morris Foundation and support by My Health My Resources (MHMR), will assure that...

Tarrant County reports 13 COVID deaths on Sunday

Tarrant County Public Health on Sunday, Sept. 20 reported 13 COVID-19 deaths, two from July and five from August. The deceased include...

CVS adds 2,000 test sites nationally; 26 in North Texas

FWBP STAFF CVS Health (NYSE: CVS) said Sept. 17 it plans to add more than...